What is MaRS Innovation?
MaRS Innovation operates as a specialized commercialization services provider and investment vehicle, representing a consortium of 14 member institutions. The firm focuses on the identification, development, and market entry of high-potential research assets. By providing both early-stage financing and operational expertise, the company acts as a catalyst for innovation, managing a portfolio that spans multiple high-growth sectors. Its business model is predicated on deep industry partnerships and a rigorous approach to deal-brokering, which allows it to navigate the complexities of intellectual property commercialization while fostering long-term value creation for its stakeholders and the broader innovation economy.
How much funding has MaRS Innovation raised?
MaRS Innovation has raised a total of $1.5M across 1 funding round:
Series A
$1.5M
Series A (2012): $1.5M with participation from Horizons Ventures, Takeda Pharmaceutical Company Ltd., and OICR
Key Investors in MaRS Innovation
Horizons Ventures
A venture capital firm with over two decades of experience, specializing in transforming early-stage startups into successful global enterprises through active involvement and equity financing.
Takeda Pharmaceutical Company Ltd.
A global, research-driven pharmaceutical leader headquartered in Japan, focused on developing innovative therapies across gastroenterology, oncology, and neuroscience.
OICR
The Ontario Institute for Cancer Research is a collaborative research organization dedicated to enabling high-impact, translational cancer research and clinical innovation.
What's next for MaRS Innovation?
Looking ahead, MaRS Innovation is poised to leverage its established network to further accelerate the maturation of its portfolio companies. The recent strategic investment of $1.5M provides the necessary liquidity to support ongoing research and development initiatives, particularly as the firm seeks to expand its global footprint. By continuing to align with strategic partners in the pharmaceutical and technology sectors, MaRS Innovation aims to enhance its deal-flow quality and increase the success rate of its commercialization efforts. The focus remains on scaling existing assets while identifying new, high-impact opportunities that align with the evolving needs of the global market, ensuring that the organization remains at the forefront of the commercialization landscape.
See full MaRS Innovation company page
